Skip to main content
Have a personal or library account? Click to login
Autologous Stem Cell Transplantation in Patients with Acute Myeloid Leukemia: a Single-Centre Experience Cover

Autologous Stem Cell Transplantation in Patients with Acute Myeloid Leukemia: a Single-Centre Experience

Acta Marisiensis - Seria Medica
Volume 59 (2013): Issue 2 (April 2013)
By: ,  ,  ,  ,   and    
Open Access
|Aug 2013
References

References

  1. 1. Apperley J, Carreras E, Gluckman E, Masszi T. The EBMT Handbook Haematopoietic Stem Cell Transplantation. 6th Revised Edition. 2012:317-326
    Search in Google Scholar
  2. 2. Tsimberidou AM, Stavroyianni N, Viniou N. Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia. Cancer. 2003;97(7):1721-1731.
    Open DOISearch in Google Scholar
  3. 3. Büchner T, Berdel WE, Schoch C, et al. Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia. J Clin Oncol. 2006; 24(16):2480-2489.
    Open DOISearch in Google Scholar
  4. 4. Harousseau JL, Cahn JY, Pignon B, et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. Blood. 1997;90(8):2978-2986.
    Search in Google Scholar
  5. 5. Isidori A, Bonifazi F, Visani G, et al. Autologous stem cell transplantation for acute myeloid patients in first complete remission: a 10-year follow-up study of 118 patients. Haematologica. 2005;90:139-140.
    Search in Google Scholar
  6. 6. Suciu S, Mandelli F, de Witte T, et al. EORTC and GINEMA Leukemia Groups- Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia(AML) in first comlete remission(CR1): an intention-to-treat analysis of EORTC/GIMEMA AML-10 trial. Blood. 2003;102:1232-1240.
    Open DOISearch in Google Scholar
  7. 7. Wang J, Ouyang J, Zhou R, et al. Autologous hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission: a meta-analysis of randomized trials. Acta Haematol. 2010;124(2):61-71.
    Open DOISearch in Google Scholar
  8. 8. Gordon MY, Blackett NM, Lewis JL, et al. Evidence for a mechanism that can provide both short-term and longterm haemopoetic repopulation by a seemingly uniform population of primitive human haemopoetic precursor cells. Leukemia. 1995;9:1252-6.
    Search in Google Scholar
  9. 9. Villaon L, Odriozola J, Larana JG, et al. Autologous peripheral blood progenitor cell transplantation with <2x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment. Hematol J. 2000;1: 374-81.
    Open DOISearch in Google Scholar
  10. 10. Vellenga E, van Putten W, Ossenkoppele GJ, et al. Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood. 2011;118(23):6037-42.
    Open DOISearch in Google Scholar
  11. 11. Ferrara F. Renaissance of autologous stem cell transplantation for AML? The Lancet Oncology. 2012;13(2):121-3.
    Open DOISearch in Google Scholar
  12. 12. Mehta J, Powles R, Sirhohi B, et al. Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pre-transplant therapy limited to patients with good karyotypes. Blood. 2001;98(Suppl 1):716a.
    Search in Google Scholar
  13. 13. Linker C. The role of autologous transplantation for acute myeloid leukemia in first and second remission. Best Pract Res Clin Haematol. 2007;20:77-84. Review.
    Open DOISearch in Google Scholar
  14. 14. Gorin NC, Labopin M, Frassoni F, et al. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol. 2008;26:3183-3188.
    Open DOISearch in Google Scholar
  15. 15. Thomas X, Suciu S, Rio B, et al. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study. Haematologica. 2007;92:389-396.
    Open DOISearch in Google Scholar
  16. 16. Burnett AK, Mohite U. Treatment of older patients with acute myeloid leukemia-new agents. Semin Hemat. 2006;43:96-106.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/amma-2013-0021 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 91 - 93
Published on: Aug 13, 2013
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
acute myeloid leukemia,
autologous stem cell transplantation
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2013 Enikő Kakucs, I Benedek, Erzsébet Benedek, Judit Beáta Köpeczi, Aliz Tunyogi, Monica Istrati, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons License.

Volume 59 (2013): Issue 2 (April 2013)
Previous article
Next article